Brookfield Corp’s Lifestance Health LFST Stock Holding History

Brookfield Corp’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-230,238	Closed	-$3.34M	–	696
2021 Q3	$3.34M	Buy	230,238 +44,687	+24%	+$860K	0.01%	274
2021 Q2	$5.17M	Buy	+185,551	New	+$4.9M	0.02%	208

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brookfield Corp's LFST Position: Q4 2021 in Review

Brookfield Corp sold out of Lifestance Health (LFST) in Q4 2021, closing a stake of 230,238 shares — an estimated $3.34M sold.

Brookfield Corp first reported a position in LFST in Q2 2021 and held it in 2 quarters. The position peaked at $5.17M in Q2 2021. 66 funds tracked by Wall St. Rank hold LFST as of Q4 2021.

Brookfield Corp reported no remaining Lifestance Health position as of Q4 2021 after selling out during the quarter.
Brookfield Corp sold 230,238 Lifestance Health shares in Q4 2021, an estimated $3.34M.
Brookfield Corp first reported a position in Lifestance Health in Q2 2021 and held it in 2 quarters.
Brookfield Corp's Lifestance Health position peaked at $5.17M in Q2 2021.
66 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2021.

Based on Brookfield Corp's 13F filing for Q4 2021, filed 14 Feb 2022.